why choose us

First received: August 01, 2022

Clinical Trial: Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Study Status: Completed

Recruit Status: RECRUITING

Condition: Carcinoma, Hepatocellular

Study Type: INTERVENTIONAL


Official Title: CSP #2023 - Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI (The PREMIUM Study)

Brief Summary: The study is a randomized trial of two different screening methods for early detection of liver cancer in patients with cirrhosis of the liver.The goal of PREMIUM is to compare an abbreviated version of the diagnostic gold standard for HCC (aMRI) +AFP to the standard-of-care screening (US+AFP) in patients at high risk of developing HCC.The investigators hypothesize that HCC will be detected at earlier stages, allowing for more curative treatments and resulting in a reduction in HCC-related mortality.

Read more